2m 2m 2m 2m 2m 2m 2m
Swe Orphan Biovi (BIOVF)
OTC
$51.05+$5.33 (+11.67%)
Price as of Nov 09, 2026- N/AMarket Cap
- 46.36%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Swe Orphan Biovi (BIOVF)
$51.05+$5.33 (+11.67%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$51.05
$51.05
$51.05
1-Year Range
$35.25
$51.05
$51.05
Latest Close$51.05
Change
+$5.33 (+10.45%)
Volume100
Information as of 11/09/2026
Company Profile
SWEDISH ORPHAN BIOVIT ORD
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
SWEDISH ORPHAN BIOVIT ORD
Key Executives
- Guido Oelkers
- Henrik Stenqvist
- Duane H. Barnes
- Mahmood Ladha
- Lydia Abad-Franch
Current Ownership Distribution
- Other342.7M (98.48%)
- Mutual Funds5.3M (1.52%)
- Institutions10,067 (0.003%)
- Insiders0 (0.00%)